Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
Seasonal monitoring of epidemic triggers for West Nile Virus (WNV) NAT tested donations will begin J...
TEMPE, Ariz. (Sept. 8, 2022) — Marion Lanteri, Ph.D., began this week as Creative Testing Solu...
On June 13, 2019, the new CTS Laboratory Information System was successfully implemented in Cha...
CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...
Creative Testing Solutions, the largest nonprofit blood testing organization in the U.S., today anno...
As an organization dedicated to the safety of the world’s blood and plasma supply, Creative Testing...